How do you calculate cell therapy quote margin?

Subtract the required cost or target recovery from the quoted sell price or program revenue, then divide by the reference price and multiply by 100. On $1,250,000 of revenue against $980,000 of required recovery, that is $270,000 of margin, or 21.6%.

What is a good margin on cell and gene therapy equipment?

Capital CGT equipment and integrated programs commonly target 20–35% gross at quote depending on customization and regulatory support. The 21.6% in the example is a workable but conservative figure for a capital-heavy program.

Is program revenue the right number to quote margin on?

Yes — use total program revenue or the equipment sell price as the top line, and put all the cost you must recover (equipment, integration, qualification support) into the cost figure so the margin reflects the whole quoted scope.

Why does my CGT program margin shrink after the quote?

Validation runs, deviations, extra qualification cycles and regulatory documentation rarely make it fully into the target recovery, so a 21.6% quote margin often erodes by several points by the time the program closes out.

Margin vs markup on cell therapy equipment — what is the difference?

Margin is profit over price; markup is profit over cost. The same $270,000 spread is a 27.6% markup on $980,000 cost but only 21.6% margin on $1,250,000 revenue, so always confirm which one your floor is set against.

Should regulatory and validation support be in the cost recovery?

For a defensible quote, yes. CGT programs live or die on qualification and documentation effort, so fold IQ/OQ/PQ support and regulatory hours into the required recovery rather than treating them as free.

Cell Therapy & Gene Therapy Equipment calculator

Cell Therapy Quote Margin Calculator

Cell therapy quote margin is the share of a CGT equipment sale or manufacturing program that remains as gross profit after the cost you must recover to deliver it. Capital sales teams and CDMO/CMO commercial groups use it when quoting bioreactors, fill-finish lines, isolators, cryogenic systems and full process-development programs to therapy developers. It matters because cell and gene therapy programs carry high capital values, single-batch criticality and intense scrutiny on cost recovery, so margin discipline at quote protects the program through long validation and tech-transfer timelines. Commercial leaders gate quotes against a target recovery and margin floor before release.

What this calculator does

Calculate quote margin percentage for a cell therapy, gene therapy, equipment, or GMP manufacturing quote.
an estimator or commercial lead is checking margin on a cell therapy, gene therapy, CDMO, or equipment quote
It computes the gross margin in dollars and as a percentage between your quoted sell price or program revenue and the cost or target recovery required to deliver it.

Formula used

Quote margin dollars = quoted sell price or program revenue - required cost or target recovery
Quote margin percentage = quote margin dollars ÷ reference price for margin reporting × 100

Inputs explained

Quoted sell price or program revenue: Enter the proposed price for the patient batch group, vector campaign, equipment package, service scope, or program.
Required cost or target recovery: Include materials, labor, suite time, QC, validation, depreciation, supplier cost, and contingency that must be recovered.
Reference price for margin reporting: Use quoted sell price for gross margin percentage or another approved reference amount for internal reporting.

How to use the result

Use it when finalizing a capital equipment quote or a CDMO program proposal, before committing the price to a therapy developer.
It is a gross quote margin and excludes validation effort, qualification runs, regulatory support and warranty, so the realized program margin is typically lower.

Current U.S. benchmarks

U.S. manufacturing runs at 75.6% of capacity with new factory orders at $657B per month (Federal Reserve and Census, May 2026).
Steel mill PPI stands at 348.53 (BLS, May 2026), up 6.7% from a year earlier. New factory orders are up 2.3% year over year (Census).

Common questions

How do you calculate cell therapy quote margin? Subtract the required cost or target recovery from the quoted sell price or program revenue, then divide by the reference price and multiply by 100. On $1,250,000 of revenue against $980,000 of required recovery, that is $270,000 of margin, or 21.6%.
What is a good margin on cell and gene therapy equipment? Capital CGT equipment and integrated programs commonly target 20–35% gross at quote depending on customization and regulatory support. The 21.6% in the example is a workable but conservative figure for a capital-heavy program.
Is program revenue the right number to quote margin on? Yes — use total program revenue or the equipment sell price as the top line, and put all the cost you must recover (equipment, integration, qualification support) into the cost figure so the margin reflects the whole quoted scope.
Why does my CGT program margin shrink after the quote? Validation runs, deviations, extra qualification cycles and regulatory documentation rarely make it fully into the target recovery, so a 21.6% quote margin often erodes by several points by the time the program closes out.
Margin vs markup on cell therapy equipment — what is the difference? Margin is profit over price; markup is profit over cost. The same $270,000 spread is a 27.6% markup on $980,000 cost but only 21.6% margin on $1,250,000 revenue, so always confirm which one your floor is set against.

Last reviewed 2026-05-12.